4D Molecular Therapeutics Statistics
Total Valuation
FDMT has a market cap or net worth of $484.06 million. The enterprise value is $134.10 million.
Important Dates
The next estimated earnings date is Friday, February 27, 2026, after market close.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FDMT has 51.01 million shares outstanding. The number of shares has increased by 10.07% in one year.
| Current Share Class | 51.01M |
| Shares Outstanding | 51.01M |
| Shares Change (YoY) | +10.07% |
| Shares Change (QoQ) | +0.36% |
| Owned by Insiders (%) | 3.64% |
| Owned by Institutions (%) | 56.62% |
| Float | 36.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4,033.87 |
| Forward PS | 14.30 |
| PB Ratio | 1.20 |
| P/TBV Ratio | 1.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1,117.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.42, with a Debt / Equity ratio of 0.06.
| Current Ratio | 8.42 |
| Quick Ratio | 8.22 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -45.38% and return on invested capital (ROIC) is -29.32%.
| Return on Equity (ROE) | -45.38% |
| Return on Assets (ROA) | -27.64% |
| Return on Invested Capital (ROIC) | -29.32% |
| Return on Capital Employed (ROCE) | -58.75% |
| Weighted Average Cost of Capital (WACC) | 19.74% |
| Revenue Per Employee | $529 |
| Profits Per Employee | -$921,485 |
| Employee Count | 227 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +69.46% in the last 52 weeks. The beta is 2.98, so FDMT's price volatility has been higher than the market average.
| Beta (5Y) | 2.98 |
| 52-Week Price Change | +69.46% |
| 50-Day Moving Average | 9.08 |
| 200-Day Moving Average | 6.96 |
| Relative Strength Index (RSI) | 62.41 |
| Average Volume (20 Days) | 765,213 |
Short Selling Information
The latest short interest is 9.48 million, so 18.58% of the outstanding shares have been sold short.
| Short Interest | 9.48M |
| Short Previous Month | 8.68M |
| Short % of Shares Out | 18.58% |
| Short % of Float | 25.77% |
| Short Ratio (days to cover) | 8.09 |
Income Statement
In the last 12 months, FDMT had revenue of $120,000 and -$209.18 million in losses. Loss per share was -$3.74.
| Revenue | 120,000 |
| Gross Profit | -177.96M |
| Operating Income | -227.28M |
| Pretax Income | -209.18M |
| Net Income | -209.18M |
| EBITDA | -222.71M |
| EBIT | -227.28M |
| Loss Per Share | -$3.74 |
Full Income StatementBalance Sheet
The company has $305.06 million in cash and $22.26 million in debt, with a net cash position of $349.97 million or $6.86 per share.
| Cash & Cash Equivalents | 305.06M |
| Total Debt | 22.26M |
| Net Cash | 349.97M |
| Net Cash Per Share | $6.86 |
| Equity (Book Value) | 368.98M |
| Book Value Per Share | 7.89 |
| Working Capital | 275.27M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$183.50 million and capital expenditures -$1.56 million, giving a free cash flow of -$185.05 million.
| Operating Cash Flow | -183.50M |
| Capital Expenditures | -1.56M |
| Free Cash Flow | -185.05M |
| FCF Per Share | -$3.63 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -189,399.17% |
| Pretax Margin | -174,314.17% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FDMT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.07% |
| Shareholder Yield | -10.07% |
| Earnings Yield | -43.21% |
| FCF Yield | -38.23% |
Analyst Forecast
The average price target for FDMT is $34.13, which is 259.64% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $34.13 |
| Price Target Difference | 259.64% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 337.15% |
| EPS Growth Forecast (5Y) | -0.70% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FDMT has an Altman Z-Score of -0.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.55 |
| Piotroski F-Score | 2 |
